TCL Archive FDA Staff Efforts To Issue Warning Letters On Procrit Ads Were Stopped By Counsel. May 9, 2008
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
